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ABSTRACT
Objectives: Preference-based health-state valuation methods such as dis-
crete choice experiment (DCE) are claimed to be superior than attitude-
based valuation methods like visual analogue scale (VAS) and time trade-
off (TTO). We compared VAS, TTO, and DCE in terms of feasibility,
reliability, and validity using vignettes depicting moderate-risk pregnancy
at term.
Methods: People from the community (n = 97) participated in both a
panel session and an individual home assignment. Each participant valu-
ated 46 vignettes with VAS, TTO, and DCE. Each vignette consisted of ﬁve
attributes: maternal health antepartum, time between diagnosis and deliv-
ery, process of delivery, maternal outcome, and neonatal outcome. The
questionnaire included Feasibility, which we evaluated by questionnaire.
Test–retest reliability and interobserver consistency were assessed by intra-
class correlation (ICC), and variance consistency by generalization theory.
Convergent validity was determined with ICC and Cohen’s kappa;
construct validity was determined with linear regression, multinomial logit
modeling, and Kendall’s Tau-b correlation (t).
Results: The DCE was reported as most feasible (DCE: 87% vs. VAS: 69%
vs. TTO: 42%). Test–retest reliability was high overall and equal (VAS:
ICC = 0.77; TTO: ICC = 0.79; DCE: k = 0.78). The VAS had the highest
interobserver reliability (ICC = 0.73). Convergent validity between VAS
and DCE was high (k = 0.79) and there was sufﬁcient construct validity
between VAS and DCE (t = 0.68). The TTO yielded less optimal results.
Generally, neonatal andmaternal outcomes weighedmost, whereas process
outcomes weighed least in moderate-risk pregnancy at term.
Conclusions: In our context of multidimensional health states with
complex trade-offs, DCE was superior to TTO and performed equal to
VAS, with DCE displaying slightly higher user feasibility.
Keywords: conjoint analysis, health-related quality of life, panel study,
preferences, pregnancy, trade-offs, vignettes, visual analogue scale.
Introduction
The aim of economic evaluation of health-care interventions is to
support allocation decisions in the health-care system. Conven-
tional economic evaluation rests on cost-utility analysis, where
the standard unit of outcome is QALY (quality-adjusted life
year). The popularity of this approach cannot, however, conceal
the difﬁculty of valid application of QALYs as health outcome
measure in studies with real life decisions [1,2]. The attitude-
based valuation methods underlying the QALY model, such as
the visual analogue scale (VAS) and the time trade-off (TTO)
have in common that they are difﬁcult to apply to complex
multidimensional health states. Multidimensional health states
have features like multiple outcomes, process, time spans, and
multiple patients, and where none of the features of one alterna-
tive is dominant over the other [3,4].
A recently proposed method to overcome this difﬁculty is
discrete choice experimentation (DCE) with conjoint analysis as
its main analytic method. DCE is a preference-based valuation
method in which a value function for multiple outcomes can be
obtained [5]. Although some claim superiority of the preference-
based DCE over attitude-based valuation methods such as VAS
and TTO in the valuation of multidimensional health states,
head-to-head comparisons are scarce [3,6–8]. It is important to
understand how the valuation methods relate to each other as
different valuation methods can lead to different decision out-
comes. Nevertheless, the lack of a gold standard makes compari-
son difﬁcult; therefore, external parameters are needed to
compare health-state valuation methods.
The aim of the study is to test the feasibility, reliability, and
validity of the direct (VAS, TTO) and indirect (DCE) valuation
methods in the absence of a gold standard, applied in the con-
text of multidimensional, condition-speciﬁc, health states with
complex trade-offs like maternal versus fetal/neonatal outcomes
[9]. The context of the study is the prototypical decision problem
between induction of labor and expectant management in term
pregnancies complicated with either pregnancy-induced hyper-
tension (PIH), preeclampsia (PE) or with an intrauterine growth
restricted (IUGR) fetus. Induction of labor is associated with
increased risk of cesarean section with associated consequences
for mother and child. Expectant management, however, is asso-
ciated with elevated risk of adverse fetal and maternal antenatal
health but is thought to lower the risk of perinatal interventions
[10–12].
Methods
Valuation Methods
In this study, we compared the attitude-based methods VAS and
TTO with the preference-based DCE.
The VAS is a psychometric valuation method with either
assumed equal-interval categories or an assumed continuous
scale with or without calibration. The VAS was ﬁrst applied in
the context of health measurement in the early 1970s [13]. The
administration of the VAS is claimed to be straightforward,
simple, and cheap [14,15]. In our study, the VAS was represented
as a 100-point 25 cm vertical line ranging from 0: “worst imag-
inable health state” (lower anchor) to 100: “best imaginable
health state” (upper anchor). We asked the participants to draw
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a horizontal line intersecting the VAS where he or she thought the
concerning health state should be positioned, considering the
anchors.
The TTO was proposed by Torrance in 1972 [16]. Using
standard TTO, respondents are asked to state the maximum
amount of time in full health that they are willing to trade-off for
a suboptimal health state such that the two are indifferent. The
maximum number of years to trade-off is not standardized, but
varies between 1 and 10 years across studies [4,17–19]. The TTO
in our study allowed respondents to trade-off a minimum of 0
days and a maximum of 10 years. Our TTO involved a two-step
rating: ﬁrst, the respondent had to state how much time he or she
was roughly willing to trade, and second, the respondent stated
how much time he or she was exactly willing to trade [20]. In this
speciﬁc context, we asked respondents to state how much of the
mother’s time of life in full health he or she was maximally
willing to trade to attain full health for both mother and child,
given the health state as presented in the vignette.
The DCE was developed in the early 1960s in the ﬁelds of
economics and psychology for marketing research purposes [21].
Translated to the health-care context, a DCE elicits patients’
preferences for a ﬁxed number of different aspects (“attributes”)
of a health state by presenting hypothetical choices between two
or more scenarios in which the levels of the attributes are sys-
tematically varied [22]. Part of the analytical ﬂexibility rests on
the assumptions that the contribution of the attributes are inde-
pendent and that the person effects are at random. The claimed
advantages of DCE are that it is a feasible and valid measurement
tool, and that it has strong connection to decision theory: its
three underlying key axioms (completeness, stability, rationality)
have been investigated with positive results [23,24]. In our study,
the stated preference between two alternative vignettes was a
forced choice.
Vignettes
We interviewed 10 patients from two randomized clinical trials
PIH and PE (the HYPITAT trial, ISRCT08132825 [12]) and on
intra-uterine growth restriction (IUGR; the DIGITAT trial,
ISRCT10363217 [10]), and 10 medical experts (gynecologists,
obstetricians, neonatologists, pediatricians) about the physical,
psychological, and social burden and consequences of PIH, PE,
and IUGR. A list of 42 aspects associated with PIH, PE, and
IUGR emerged, which could be summarized into seven
attributes.
After pilot testing the attribute, “episiotomy” did not yield
signiﬁcant valuations, whereas “induction of labor” and
“process of delivery” were merged into one attribute (“process of
delivery”) [25]. The ﬁve present-study attributes were: “maternal
health antepartum,” “time between diagnosis and delivery,”
“process of delivery,” “maternal outcome,” and “neonatal
outcome.” The attribute levels were chosen according to the
interviewees’ responses, literature review, and the expected
primary and secondary outcomes from the HYPITAT [12] and
DIGITAT [10] trials. Each attribute had 2 to 7 levels; all were
deﬁned with certainty (i.e., without risks or chances).
We converted the attributes into 297 ¥ 210 mm (11.7 ¥ 8.3
inch) sized vignettes with both a visual and a written represen-
tation of the attributes and levels. The visual representation
depicts a timeline to visualize the course of health states of both
mother and child over time. The timelines start now of diagnosis
(PIH, PE, or IUGR), and ends 1 year postpartum. A box above
the maternal timeline depicts the process of delivery: induction of
labor, onset of delivery, and mode of delivery. Colors were used
to display severity of complications: “normal situation” (blue),
“some complications” or “moderate physical health” (yellow),
and “severe complications” or “poor physical health” (red). The
explanation of the colors and terms were given on a separate
reference sheet.
Factorial Design
The total number of usable unique vignette pairs (x) is deﬁned as
x = [(y - z)2 - (y - z)]/2, where y is the total number of attribute-
level combinations and z is the number of clinically impossible
attribute-level combinations. Applied to our study, y = 630 and
z = 210, which makes x = 37.990 vignette pairs.
Because of the large number of usable vignette pairs, we
applied an incomplete factorial design, which is composed of a
random draw stratiﬁed for what we coin the “stress factor” (see
also Huber and Zwerina [26]). The stress factor of a vignette pair
represents the difﬁculty of a choice and is determined by 1) the
proximity, estimated as the net difference of the pilot VAS scores
between the vignettes; and 2) the number of overlapping
attribute levels. The higher the proximity and the lower the
number of overlapping attribute levels, the higher the stress
factor. We categorized proximity into four classes, and the
number of overlapping attribute levels into three classes, which
resulted in 4 ¥ 3 = 12 different stress factors.
A set of 240 single (120 paired) vignettes was randomly
drawn stratiﬁed by stress factor, assuming that 90 participants
could be included, that every participant could valuate a
maximum of 40 single vignettes with the VAS and TTO, and 20
paired vignettes with the DCE, and that we need 15 observations
per (single or paired) vignette. As this approach does not guar-
antee ex ante that the assumptions of orthogonality and level
balance are achieved, both assumptions were checked after the
set of vignettes had been randomly drawn.
Procedure
The study consisted of a panel session and a subsequent indi-
vidual home assignment. A group of 97 persons from the com-
munity participated. Most (91%) had participated in previous
health-state valuation studies [20,27]. Participants received €50
for their participation.
There were seven panel sessions, with 10 to 16 participants
per session. Each panel session was conducted by a trained
moderator (DB, GJB, JAH, or MFJ) who followed a detailed
protocol developed on the basis of the Dutch Disability Weights
[27], MiDAS [20], and IBIS [28] protocols. The 240 (120 paired)
vignettes from the randomized draw were distributed over six
booklets. Each booklet was used in a different panel session (one
booklet was used in two sessions), and consisted of two parts: 20
panel session vignettes (18 vignettes (9 paired vignettes), plus the
best and worst possible vignettes, and 26 home-assignment
vignettes (22 vignettes [11 paired vignettes], plus 4 single retest
vignettes [2 paired vignettes]).
In the panel session, the participants ﬁrst completed the DCE.
The DCE task was to choose the best vignette out of each two
paired vignettes in the booklet, considering all health-state
attributes. Next, they rated each single vignette on a VAS, and
subsequently on a TTO. For these latter two tasks, the partici-
pants had to consider all attributes of each single vignette to
assign a VAS or TTO valuation. Finally, the participants ﬁlled out
a questionnaire concerning background characteristics and
obstetric history. For each valuation method, we recorded the
amount of time of explanation and completion. Ex post anec-
dotal information and remarks from the participants were also
recorded.
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At home, the participants valued the home-assignment
vignettes in the same order as in the panel session, including the
retest vignettes with each of the three methods. They also ﬁlled
out a feasibility questionnaire, concerning comprehensibility
of the vignettes, reference handout, and the ﬁve individual
attributes, the difﬁculty of each valuation method, and the self-
reported amount of time needed to complete the home task.
Analysis
We used descriptive statistics to report the outcomes of the fea-
sibility questionnaire. Response rates for each valuation method
were calculated.
We assessed test–retest reliabilities of the VAS and TTO using
the infraclass correlation coefﬁcient (ICC; two-way random
effects, single measures, absolute agreement; 95% CI). The test-
retest reliability of the DCE was obtained with Cohen’s
unweighted kappa (95% CI). Generalization theory (G-theory)
with restricted maximum likelihood was used to determine con-
sistency of the VAS and TTO variance components. Interobserver
consistencies of the TTO, VAS, and DCE were calculated using
ICC (two-way random effects, single measures, absolute agree-
ment; 95% CI).
Convergent validity of the VAS and TTO scores is determined
using ICC (two-way random effects, consistency; 95% CI). VAS
and TTO scores were compared with the DCE scores by trans-
forming the VAS and TTO valuations into binary (DCE) scores.
We assessed level of agreement with Cohen’s unweighted kappa
(95%CI).
The TTO was coded as number of days with a maximum of
3650 (equal to 10 years). The VAS and TTO scores were trans-
formed into 0 to 1 scores using the following transformations
[17]:
VAS vas= ( )100
TTO tto 3650= − ( ) −( )⎡⎣ ⎤⎦∧1 1 61.
We used one type of regression model applied to each of the
valuation methods to achieve a valid comparison across valua-
tion methods. We obtained relative weights (coefﬁcients) of the
attribute levels by mixed model linear regression of the trans-
formed VAS and TTO scores, and by application of a multino-
mial logit (conjoint analysis) on the DCE scores. Construct
validity was assessed by pair-wise comparison of the relative
weights of each two methods using Kendall’s Tau-b correlation.
Analysis was conducted using SPSS 15.0 for Windows (SPSS
Inc., Chicago, IL). Multinomial logit was performed using SAS
9.1.2 (SAS Institute Inc., Cary, NC). A P-value of 0.05 (two-
sided) was considered statistically signiﬁcant.
Results
Baseline
The group of participants (n = 97) consisted of 36 (37.1%) men
(Table 1). The mean age was 51.5 years (SD 17.2), and 65
(63.7%) participants had at least one child. Half (48.5%) of the
people had no physical limitations on the EuroQoL 6D3L. Three
people reported severe pain/discomfort and severe depression/
anxiety. All participating mothers and the partners of all partici-
pating fathers had some form of adverse experience during
pregnancy, labor, or postpartum.
Feasibility
Table 2 shows participants’ self-reported feasibility of the written
and visual component of the vignettes, the reference handout, the
individual attributes, and the valuation methods. The majority
considered the written and visual components of the vignettes to
be comprehensible (86–87%). The attribute “process of deliv-
ery” was the most comprehensible (96–98%), and “time between
diagnosis and delivery” was least comprehensible (87–91%). The
attributes presented visually were systematically (but not signiﬁ-
cantly) rated more comprehensible than the written ones. Fur-
thermore, several participants orally reported to appreciate the
graphical support of the textual information on the vignettes.
Overall, the participants rated the DCE as “easy,” the VAS as
“neutral,” and the TTO as “difﬁcult.” Differences by age or
gender were absent. Time for explanation and completion was on
average 25 minutes for the VAS, 40 minutes for the TTO and 10
minutes for the DCE. The mean self-reported time to complete
the home assignment was 57 minutes (range: 20–300). No
gender or age effects were found. The home assignment was
completed by 87.6% (VAS), 82.5% (TTO), and 93.8% (DCE) of
participants.
Reliability
The time interval between test and retest ranged from 3 to 21
days, with a median of 5 days. The test–retest ICC for VAS was
Table 1 Descriptive statistics of age, number of biological children, age
of youngest child, obstetric history, and self-reported health
Baseline characteristics (n = 97)
Age in years (mean; range) 51.5 21–79
Number of children (mean; range) 1.4 0–6
Age youngest child in years (mean; range) 22.2 0.1–55
Education:10 years (n;%) 21 21.6
Education: 11 to 13 years (n;%) 40 41.2
Education:14 years (n;%) 36 37.1
Household income:€1600 p/m (n;%) 39 40.2
Household income: €1601 to €3400 p/m (n;%) 37 38.1
Household income:€3401 p/m (n;%) 6 6.2
Obstetric history (n = 65) n %
Complications during pregnancy, of which: 56 86.2
- PIH, PE or SGA 16 24.6
- Other mild* 25 38.5
- Other severe† 4 6.2
Complications during labor, of which: 42 64.6
- Cesarean section 5 7.7
- Other mild‡ 29 44.6
- Other severe§ 7 10.8
Maternal complications postpartum, of which: 24 36.9
- Mild 17 26.2
- Severe¶ 6 9.23
Neonatal complications postpartum, of which: 19 29.2
- Low birth weight neonate 5 7.7
- Other mild# 11 16.9
- Other severe** 4 6.2
Self-reported health: EuroQoL 6D3L- level 1 n %
Mobility 82 84.5
Self-care 96 99.0
Usual activities 81 83.3
Pain/discomfort 59 60.8
Anxiety/depression 82 84.5
Cognition 84 86.6
*Gestational diabetes, ﬂuid build-up, breech presentation, umbilical cord around baby’s neck,
hip joint instability, breast infection.
†HELLP syndrome, extra-uterine pregnancy, vein thrombosis, neuroﬁbromatosis.
‡Induction of labor, vacuum/forceps extraction, episiotomy, too weak/too strong contrac-
tions, breech delivery.
§Severe blood ﬂux, fetal distress, emergency admission during delivery.
Complications because of episiotomy or section caesarea, incontinence, pain in hips, and
back, blood ﬂux, uterine infection.
¶Total rupture, extended period of recovery, postnatal depression, maternal death.
#(Breast)feeding complications, mild hydrocephalus, birth-related injury, cleft palate.
**Myotonic dystrophy, admission to NICU, neonatal death.
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0.77 (95%CI: 0.73–0.81), and for TTO 0.79 (95%CI: 0.75–
0.83). Cohen’s kappa for DCE was 0.78 (95%CI: 0.69–0.89).
Table 3 shows the G-theory variance components for the VAS
and TTO scores. The sums of variance of the health-state
attributes (main effects) were 75.8% (VAS), and 41.0% (TTO).
“Neonatal health postpartum” was the attribute with the highest
proportion of variance (VAS: 63.5%; TTO: 39.5%). In the TTO,
the interaction between respondent and attribute “Neonatal
health postpartum” was substantial (37.2%). The proportion of
the variance of respondent characteristics (main effects) was only
6.8% (VAS) and 5.8% (TTO), respectively.
The interobserver ICC for the VAS was 0.73 (95% CI: 0.58–
0.87), 0.33 (95% CI: 0.20–0.55) for the TTO, and 0.64 (95%
CI: 0.50–0.79) for the DCE.
Validity
Convergent validity ICC between VAS and TTO was 0.72
(95%CI: 0.70–0.74). Cohen’s kappa for agreement between VAS
and DCE was 0.79 (95%CI: 0.77–0.82), and between TTO and
DCE 0.77 (95%CI: 0.74–0.81).
The relative weights (coefﬁcients) from the VAS, TTO, and
DCE scores are presented in Table 4. Kendall’s Tau-b was 0.68
between VAS and DCE (P < 0.001), 0.43 between TTO and DCE
(P = 0.029), and 0.42 between VAS and TTO (P = 0.029).
Discussion
We compared the VAS, TTO, and DCE head-to-head in terms of
feasibility, reliability, and validity. The feasibility of the valuation
methods showed a clear ranking: participants considered the
DCE to be the easiest, TTO the most difﬁcult, whereas VAS
scored in between. The test–retest reliability was surprisingly
high and comparable throughout the three valuation methods
but interobserver consistency was different: high for VAS, slightly
lower for DCE, and low for TTO. Despite the slightly different
psychometric proﬁle of VAS and DCE, both methods generated
comparable weights whereas TTO did not.
Table 2 Descriptive statistics for self-reported feasibility of the written and visual components of the vignettes, reference, attributes, and valuation
methods
Overall feasibility of vignettes
Comprehensible
n (%)
Neutral
n (%)
Incomprehensible
n (%)
Written component 72 (86.7) 10 (12.0) 1 (1.2)
Visual component 74 (86.0) 12 (14.0) 0 (0)
Reference 75 (87.2) 10 (11.6) 1 (1.2)
Feasibility per attribute
Written component Visual component
Comprehensible
n (%)
Incomprehensible
n (%)
Comprehensible
n (%)
Incomprehensible
n (%)
Maternal health antepartum 77 (91.7) 7 (8.3) 83 (95.4) 4 (4.6)
Time between diagnosis and delivery 73 (86.9) 11 (13.1) 79 (90.8) 8 (9.2)
Process of delivery 81 (96.4) 3 (3.6) 85 (97.7) 2 (2.3)
Maternal complications postpartum 78 (91.8) 7 (8.2) 81 (93.1) 6 (6.9)
Neonatal complications postpartum 78 (91.8) 7 (8.2) 82 (94.3) 5 (5.7)
Overall feasibility of methods
Easy
n (%)
Neutral
n (%)
Difﬁcult
n (%)
VAS 18 (20.7) 42 (48.3) 27 (31.0)
TTO 8 (9.2) 28 (33.3) 50 (57.5)
DCE 50 (58.1) 25 (29.1) 11 (12.8)
Table 3 G-theory: estimated variance components in percentages of
the respondent characteristics, health state attributes, and interaction
terms between attributes and respondents for the visual analogue scale
(VAS) and the time trade-off (TTO)
Source of variation VAS % TTO %
Respondent (R) 5.01 1.67
Respondent age 1.17 1.52
Respondent sex 0.34 1.33
Respondent has children 0.26 0.00
Respondent’s educational level 0.00 0.95
Respondent’s income 0.00 0.72
Maternal health antepartum (A1) 0.06 0.01
Time between diagnosis and delivery (A2) 0.01 0.00
Process of delivery (A3) 0.96 0.02
Maternal outcome (A4) 11.29 1.41
Neonatal outcome (A5) 63.47 39.50
R ¥ A1 0.00 0.14
R ¥ A2 0.00 0.00
R ¥ A3 0.00 0.00
R ¥ A4 1.64 1.79
R ¥ A5 6.01 37.24
Residual (e) 15.95 17.23
Table 4 Relative weights (coefﬁcients) from the VAS and TTO mixed
model linear regression and from the DCE multinomial logit
Attribute and level (reference) VAS TTO DCE
Maternal health antepartum (normal)
- Moderate 0.006 0.025 -0.008
Time between diagnosis and delivery (3 days)
- 1 week -0.008 -0.011 -0.006
- 2 weeks -0.002 0.000 -0.004
Process of delivery (Cervical)
- Induction, cervical -0.024† 0.040 -0.062†
- Vacuum -0.014 0.049* -0.014
- Induction, vacuum -0.025† 0.058† -0.011
- Cesarean section (planned) -0.044† 0.038 0.011
- Cesarean section (not planned) -0.043† 0.033 -0.026
- Induction, Cesarean section (not planned) -0.037† 0.082† -0.023
Maternal outcome (3 days moderate)
- 3 days severe and 4 days moderate -0.022† -0.035* -0.043†
- 7 days severe and after 1 year moderate -0.122† -0.075† -0.163†
Neonatal outcome (No complications)
- 7 days moderate -0.027† -0.011 -0.023
- 3 days severe and 7 days moderate -0.059† 0.004 -0.068†
- 10 days severe and after 1 year moderate -0.184† -0.060† -0.208†
- 3 days severe and death -0.382† -0.480† -0.331†
*P 0.05; †P 0.01.
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Our aim was to use vignettes coming close to clinical reality
in the choice between intervention and expectative policies
in moderate-risk pregnancy at term. Several layouts of the
vignettes were constructed, piloted, and optimized along
the development process. Overall, participants regarded the
vignettes as comprehensible and they appreciated the graphical
support alongside written information instead of written infor-
mation only—the conventional approach. Participants under-
stood the attribute “number of days waiting” less well. Maybe
the participants found it difﬁcult to imagine waiting as a policy
option while having a moderate-risk pregnancy, although we
emphasized the rationale of the waiting period. Another possi-
bility is that waiting in uncertainty—a situation well known
from clinical practice—is difﬁcult to communicate ex ante by
vignettes only.
Participants found it easier to select one out of two alterna-
tives than to assign assumed interval-scale valuations to a single
health state. The cognitive load of applying VAS or TTO, in
which all attributes have to be considered simultaneously to
assign a valuation, can be considerable [29]. In contrast, DCE
demands a smaller cognitive load than VAS or TTO, as the study
of Maddala and coworkers shows, because cognitive shortcuts
can be made by focusing only on the attributes that differ
between the vignettes thereby ignoring overlapping attributes
[30]. We should emphasize however that vignettes with higher
overlap are not typical of DCE. Paired comparisons of vignettes
with a high “stress factor” (i.e. high vignette weight proximity
and no overlapping attributes) can be quite difﬁcult as well [26].
Hence, the apparent feasibility of DCE in this respect could have
been partly induced by the vignette design. Although standard
TTO has proved to be feasible in various health outcome valu-
ation studies (e.g. [19,29,31,32]), our participants regarded TTO
less feasible. We are aware that the TTO task was put to the
extreme by requiring participants to trade the mother’s survival
time for the optimal joint outcome of mother and infant, par-
ticularly in vignettes that involved neonatal death.
Test–retest reliability was overall high but interobserver con-
sistency differed across methods. We do not think that recall bias
caused the high test–retest reliability because the vignettes were
complex and because we administered them as part of a large set
of vignettes. The test–retest reliabilities of the three methods were
good, indicating that possible bias because of location or setting
was minimal or absent. Consistent, extreme answers partly
caused the high TTO test–retest reliability. These results indicate
that participants more or less agreed on the overall ranking of
vignettes but that opinions on the optimal amount to trade-off
were diverse, particularly in the very adverse health states. The
interaction effects between respondent and the attributes “mater-
nal outcome” and “neonatal outcome” (Table 3) support the
notion of the individual and nonlinear use of the TTO scale, as
reported by others [4].
We will discuss some limitations of the study. First, we cannot
exclude that any ordering effect have occurred because the order-
ing of the valuations tasks (DCE, VAS, TTO) was the same in the
panel and home assignment tasks. Nevertheless, the DCE and
VAS are highly different valuation tasks, with different stimuli
and response modes, so an ordering effect does not appear likely.
Similarly, an ordering effect may have occurred between VAS and
TTO, but the discrepancy between VAS and TTO is still large
indicating that the extent of the ordering effect (if any) appears
small. Second, the VAS revealed more signiﬁcant coefﬁcients than
DCE. Nevertheless, the larger weights actually were all statisti-
cally signiﬁcant (Table 4) whereas the lower weights were not. Of
course, smaller nonsigniﬁcant weights may become signiﬁcant
when taking a larger sample of respondents and/or vignettes, but
remain small and not attaining clinical relevance. Third, we used
one common regression model. The choice of this regression
model may have inﬂuenced the estimation of relative weights. We
aimed at comparison of relative weights across different valua-
tion methods; we were not searching for the best explanatory
regression model for each valuation method separately. Such a
comparison can only be valid when different valuation methods
are compared in terms of one common regression model. Finally,
our study used complex multipatient multidimensional vignettes
in obstetrics as clinical context. It is unclear if our results also
apply to other complex decision problems in obstetrics. The
uncertainty is even larger for the generalizability to other medical
ﬁelds—with or without the application of complex vignettes.
Further research should clarify that issue.
VAS, TTO, and DCE all point to the same conclusion: The
ranking of the relative weights assigned to the attributes-levels is
the same, regardless of the valuation method chosen. Neonatal
outcome, and to a lesser extent maternal outcome, are the most
important factors when deciding between induction of labor
and expectant management, whereas length of waiting time,
health status while waiting, and mode of delivery are subordi-
nate. These ﬁndings are in agreement with clinical practice. The
comparison of the dichotomized VAS and TTO scores with the
crude DCE preference scores also revealed comparable agree-
ment between methods at the vignette level. But only VAS and
DCE had satisfactory agreement in terms of ranking of relative
attribute weights, with the VAS showing more sensitivity for
process outcomes (mode of delivery) than the DCE. Earlier
studies report also agreement between VAS and TTO attribute
weights, unlike in our study [4,17,33]. The TTO rankings may
have been deviant particularly because the TTO valuations were
subject to individual use of the scale. That TTO performed less
well in our study does not imply that the TTO should be
avoided in general or in all cases, but rather that the TTO
should be used with caution within our speciﬁc obstetrical
context. That the outcomes of VAS and DCE highly converged
may be because both methods are based on the ranking of
vignettes [34].
Despite the similarity of the attitude-based VAS and the
preference-based DCE, the two methods differ considerably from
a conceptual perspective. The VAS uses a preconstructed metric
scale with predeﬁned anchors, which allows interpretation of
valuations of all possible health states at both the individual and
the group level. A drawback of the VAS, however, is that valua-
tions may be subject to individual use of the scale (e.g. interpre-
tation of anchors). Another drawback is that a VAS score is a
composite valuation which does not allow the decomposition of
valuation into attributes, and that the valuation task can be quite
demanding when the number of vignettes is large. In contrast, the
DCE does not have a preconstructed metric scale, but a metric
scale is constructed post hoc as part of the analysis, which allows
interpretation of valuations (and ranking of vignettes) at the
group level, but not on the individual level. An advantage of DCE
is that a subset of vignettes can be used to decompose valuation
into the relative weights of attributes, which is efﬁcient when a
large set of vignettes is to be valued. A disadvantage of DCE is
that comparisons across different domains (contexts) are only
possible when they share common attributes. An analytical dis-
advantage of DCE is that DCE uses a set of partly untestable
assumptions, where valuations of vignettes are based on error-
free frequency-based partial rankings of alternatives within the
choice set [7,24]. The different concept, the unstandardized selec-
tion of choice sets, and the untestable assumptions underlying
DCE require a conditional judgment on the comparability of
DCE with other methods.
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Valuations or preferences of health states may be elicited to
support decision making both at the societal level (e.g. cost-
effectiveness analysis; development of clinical guidelines) as well
as in individual clinical decisions (e.g. treatment selection)
[35–38]. Regardless of the perspective chosen, the valuation
method should be feasible, valid, and reliable. In case of societal
decision making, interobserver reliability is more important than
test–retest reliability. When the set of possible health states is
large, DCE may be particularly helpful to reduce the amount of
health states to a limited number of attributes and attribute
weights. In case of individualized decision making, test–retest
reliability appears more important than interobserver reliability.
When the aim of individualized decision making is to select an
optimal treatment for that speciﬁc patient, and the set of health
states is relatively small, a conventional approach (e.g. VAS or
TTO) may be more efﬁcient than the rather cumbersome DCE
approach. The ultimate method selected therefore depends on its
speciﬁc application and context.
Summarizing, our study showed that the VAS and DCE per-
formed equally well in a complex decision context. From the
respondent’s perspective, a DCE might be more feasible, but
from a researcher’s point of view, a VAS might be easier to apply;
the DCE requires a well-balanced and more complex choice
design, and the more difﬁcult conjoint analysis [26]. The claimed
superiority of DCE over TTO in our context has been conﬁrmed.
When QALYs of complex health states with multiple trade-offs
are calculated to support societal resource allocation decisions,
we recommend the use of the preference-based DCE method over
the attitude-based valuation methods such as TTO. Nevertheless,
the superiority of DCE over VAS appeared to be restricted to
applications in which user feasibility plays a major role.
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